Myanmar vs Togo: Cause of death, by non-communicable diseases, ages 5-14, female
Myanmar
26.0%
in 2021
Togo
26.9%
in 2021
Myanmar rank
136th
Togo rank
134th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Myanmar
- Togo
How they compare
Togo currently reports 26.9% against 26.0% in Myanmar, a difference of 0.9%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Myanmar ahead.
Myanmar ranks 136th and Togo ranks 134th of 184 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.2% | 14.8% | 6.4% | Myanmar |
| 2010s | 29.4% | 22.7% | 6.7% | Myanmar |
| 2020s | 29.6% | 27.0% | 2.6% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Myanmar or Togo?
- Togo, at 26.9% against 26.0% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Myanmar and Togo?
- 0.9%, with Togo ahead.
- How many years of comparable data are there for Myanmar and Togo?
- 6 years are reported by both, from 2000 to 2021.
- How do Myanmar and Togo rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Myanmar ranks 136th and Togo ranks 134th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.